Triiodothyronine
Research News and Information

Sunday, November 22, 2009

Type 1 deiodinase activity and generation of triiodothyronine (T3) in prostate of sexually active rats.

30 Oct 2009 BACKGROUND: Thyroxine (T(4)) and triiodothyronine (T(3)) are involved in the development and function of the male reproductive system. The type 1 deiodinase enzyme (D1) plays a major role in the intracellular conversion of T(4) to the active form, ... Read more...

The influence of thyroid hormones on periodontitis-related bone loss and tooth-supporting alveolar bone: a histological study in rats.

20 Oct 2009 BACKGROUND AND OBJECTIVE: Recent studies have pointed to potentially periodontal risk indicators, however no information is available on the impact of changes in thyroid hormone levels on the progression of periodontitis and on the quality of ... Read more...

Knockdown of the type 3 iodothyronine deiodinase (D3) interacting protein peroxiredoxin 3 decreases D3-mediated deiodination in intact cells.

7 Oct 2009 The type 3 iodothyronine deiodinase (D3) is the primary deiodinase that inactivates thyroid hormone. Immunoprecipitation of D3, followed by fluorescent two-dimensional difference gel electrophoresis and mass spectrometry, identified peroxiredoxin 3 ... Read more...

Latest indexed articles for 'Triiodothyronine'

These are the very latest articles for this heading:

• Type 1 deiodinase activity and generation of triiodothyronine (T3) in prostate of sexually active rats. 30 Oct 2009
• The influence of thyroid hormones on periodontitis-related bone loss and tooth-supporting alveolar bone: a histological study in rats. 20 Oct 2009
• Knockdown of the type 3 iodothyronine deiodinase (D3) interacting protein peroxiredoxin 3 decreases D3-mediated deiodination in intact cells. 7 Oct 2009
• Thyroid hormones induce cell proliferation and survival in ovarian granulosa cells COV434. 29 Sep 2009
• Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis. 18 Sep 2009
• Regular aerobic exercise training improves endothelium-dependent arterial dilation in patients with subclinical hypothyroidism. 6 Sep 2009
• Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. 6 Sep 2009
• Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms. 2 Sep 2009
• Validation and application of an immunofluorimetric assay for detection of serum free triiodothyronine and free thyroxine concentrations in buffalo (Bubalus bubalis) under various physiological conditions. 30 Aug 2009
• Autoimmune thyroid disease and autoimmune rheumatic disorders: a two-sided analysis. 30 Aug 2009
• Is there a possibility of intrasystem regulation by hormones produced by the immune cells? Experiments with extremely low concentrations of histamine. 30 Aug 2009
• Acclimation to heat during incubation: 4. Blood hormones and metabolites in broilers exposed to daily high temperatures. 30 Aug 2009
• A TRbeta-selective agonist confers resistance to diet-induced obesity. 25 Aug 2009
• The proinflammatory environment in potential heart and lung donors: prevalence and impact of donor management and hormonal therapy. 25 Aug 2009
• Contribution of individual organ mass loss to weight loss-associated decline in resting energy expenditure. 24 Aug 2009
• Dose-dependent effects of triiodothyronine on the osteogenic differentiation of rat bone marrow mesenchymal stem cells. 16 Aug 2009
• Surgery and radioablation therapy combined: introducing a 1-week-condensed procedure bonding total thyroidectomy and radioablation therapy with recombinant human TSH. 15 Aug 2009
• Diminished and irregular TSH secretion with delayed acrophase in patients with Cushing's syndrome. 15 Aug 2009
• Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study. 9 Aug 2009
• Optimal testing for thyroid hormone concentration after treatment with methimazole in healthy and hyperthyroid cats. 9 Aug 2009

See a longer list of these articles.

Technical information about 'Triiodothyronine'

Definition: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.

Chemical name: L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-

Registry Number: 6893-02-3

Descriptor UI: D014284

Alternative terms: Triiodothyronine; T3 Thyroid Hormone; Thyroid Hormone, T3; Liothyronine; Cytomel;

Related Mesh Headings: Receptors, Thyroid Hormone;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D06.472.931.740.385; D12.125.072.050.767.741.894;

Online Note: use TRIIODOTHYRONINE to search LIOTHYRONINE 1966

History Note: LIOTHYRONINE was heading 1963-66